指南与共识创伤与烧伤复苏、休克与脓毒症

优先处理循环而非气道以提高严重出血创伤患者生存率:世界急诊外科学会-泛美创伤共识声明

Prioritizing circulation over airway to improve survival in trauma patients with exsanguinating injuries: a world society of emergency surgery-panamerican trauma consensus statement.
指南 / 共识 · World J Emerg Surg · 2025-06-02
一句话结论对严重出血创伤患者,优先处理循环(CAB)较传统ABC顺序显著降低死亡率(汇总OR 3.65,95%CI 1.74-7.65,ABC死亡率更高)。

该共识基于系统综述与Meta分析,比较CAB与ABC顺序对严重出血创伤患者生存的影响。纳入6项研究共11855例患者,随机效应模型显示ABC顺序与死亡率显著升高相关(汇总OR 3.65,95%CI 1.74-7.65)。前瞻性队列亚组死亡风险更高(POR 9.99,95%CI 5.59-17.85),回顾性研究亚组POR 2.42(95%CI 1.08-5.36)。研究间异质性高(I²=92%),可能源于人群与复苏方案差异。共识旨在为严重出血创伤患者优先循环管理提供基于现有证据的共享声明。

要点

  • 对严重出血创伤患者,ABC顺序与死亡率显著升高相关(汇总OR 3.65,95%CI 1.74-7.65)。
  • 前瞻性队列研究中ABC顺序死亡风险更高(POR 9.99,95%CI 5.59-17.85),回顾性研究POR 2.42(95%CI 1.08-5.36)。
  • 纳入6项研究共11855例严重出血创伤患者,研究间异质性高(I²=92%)。
  • 共识由世界急诊外科学会与泛美创伤组织制定,旨在基于现有证据形成共享声明。

适用人群与场景

  • 严重出血创伤患者(exsanguinating hemorrhage)

研究设计与关键结果

  • 系统综述与Meta分析,纳入6项观察性或比较性研究,共11855例严重出血创伤患者,检索截至2024年9月。
  • ABC顺序与死亡率显著升高相关(汇总OR 3.65,95%CI 1.74-7.65)。
  • 前瞻性队列研究亚组ABC顺序死亡风险POR 9.99(95%CI 5.59-17.85),回顾性研究亚组POR 2.42(95%CI 1.08-5.36)。
  • 研究间异质性高(I²=92%),可能源于患者人群与复苏方案差异。

证据类型、等级与局限

  • 证据类型:系统综述与Meta分析(纳入观察性及比较性研究),采用纽卡斯尔-渥太华量表评估偏倚风险,随机效应模型计算汇总OR。
  • 局限:研究间异质性高(I²=92%),可能源于患者人群与复苏方案差异。

对床旁实践的改变

  • 作者认为,对严重出血创伤患者优先处理循环(CAB)较传统ABC顺序可显著降低死亡率。

指南或共识出处

  • 世界急诊外科学会-泛美创伤共识声明(World Society of Emergency Surgery-Panamerican Trauma consensus statement)

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

INTRODUCTION: Hemorrhage is one of the leading causes of preventable death in trauma patients. For decades, the Airway-Breathing-Circulation (ABC) approach has been the cornerstone of trauma care. However, emerging evidence suggests that prioritizing airway management in exsanguinating patients may worsen hypotension and increase mortality. This systematic review and meta-analysis aim to evaluate the effectiveness of the Circulation-Airway-Breathing (CAB) approach compared to the traditional ABC sequence in improving survival in trauma patients with severe hemorrhage.

METHODS: A systematic review was conducted in accordance with the PRISMA guidelines. Databases including PubMed and Ovid MEDLINE, SCOPUS, web of science and EMBASE were searched for studies published up to September 2024. Eligible studies included observational and comparative studies reporting outcomes of trauma patients with exsanguinating hemorrhage. The Newcastle-Ottawa Scale was used for risk of bias assessment. A meta-analysis was performed using a random-effects model to calculate pooled odds ratios (OR) for mortality, with 95% confidence intervals (CI). Subgroup analysis was conducted to compare the ABC and CAB approaches in prospective and retrospective studies.

RESULTS: Six studies (N = 11,855 patients) met the inclusion criteria. The meta-analysis revealed a significant increase in mortality associated with the ABC approach (pooled OR: 3.65, 95% CI: 1.74-7.65). Subgroup analysis of prospective cohort studies found an even higher mortality risk (POR: 9.99, 95% CI: 5.59-17.85) when compared with POR of retrospective studies (POR: 2.42, 95%CI: 1.08-5.36). High heterogeneity (I2 = 92%) was observed across the studies, likely due to variations in patient populations and resuscitation protocols.

CONCLUSION: Prioritizing circulation over airway management in trauma patients with exsanguinating injuries significantly reduces mortality compared to the traditional ABC approach. The present consensus paper, conducted according to the WSES methodology3, aims to provide a review of the literature comparing the CAB approach to the traditional ABC sequence in trauma patients with exsanguinating hemorrhage, to develop a shared consensus statement based on the currently available evidence.

来源:World J Emerg Surg,查看原文。版权归原作者所有。

参考来源

  1. Ferrada P, Shafique S, Brenner M, et al. Prioritizing circulation over airway to improve survival in trauma patients with exsanguinating injuries: a world society of emergency surgery-panamerican trauma consensus statement. World J Emerg Surg. 2025. PMID: 40457450. doi:10.1186/s13017-025-00618-2

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。